AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Bacil Pharma Limited

₹21.41 -$16.01 (-42.78%)
BSE · 16 Oct 2026 10:27 UTC
Previous Close
₹21.95
Day Range
₹20.86₹21.95
Year Range
₹10.65₹61.8
Market Cap
307.3M
AVG Volume
155.58K
Trailing/Forward PE
52.7/-
PEG ratio
-0.85
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Bombay Stock ExchangeIN
Revenue (INR) · A
0250K500K750K1M2017201820192020202120222023202420252026
BACPHAR.BO Revenue (INR) by year
PeriodRevenue (INR)
20260
2025877K
20240
20230
20220
20210
20200
20190
20180
20170
Net Income (INR) · A
-40M-20M020M2017201820192020202120222023202420252026
BACPHAR.BO Net Income (INR) by year
PeriodNet Income (INR)
202613.43M
20254.04M
2024-591K
2023-1.02M
2022-38.6M
2021-2.39M
2020-3.15M
2019-3.34M
2018-37.88M
2017-21K
Operating Income (INR) · A
-40M-30M-20M-10M02017201820192020202120222023202420252026
BACPHAR.BO Operating Income (INR) by year
PeriodOperating Income (INR)
2026-2.45M
2025-973K
2024-1.9M
2023-1.77M
2022-39.07M
2021-3.34M
2020-1.89M
2019-3.5M
2018-828K
2017-526K
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (INR) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Bacil Pharma Limited
BACPHAR.BO
Stockpicker

Video analysis: BACPHAR.BO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BACPHAR.BO

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.